BigOmics to assist Remix Therapeutics with omics data analysis in their mission to reprogram RNA processing
Remix Therapeutics is a Boston-based biotechnology company developing novel small molecule therapies for reprogramming RNA processing and treating disease in entirely new ways. As protein targeting therapies reach the limits …